United Health Products, Inc. (UEEC)
USD 0.25
(-6.37%)
USD 0.25
(-6.37%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 660.56 Thousand USD | -2.03% |
| 2022 | 674.26 Thousand USD | 241.92% |
| 2021 | 197.2 Thousand USD | -61.62% |
| 2020 | 513.87 Thousand USD | 47.17% |
| 2019 | 349.16 Thousand USD | 1608.12% |
| 2018 | -23.15 Thousand USD | -108.87% |
| 2017 | 260.88 Thousand USD | -12.74% |
| 2016 | 298.96 Thousand USD | 3.78% |
| 2015 | 288.07 Thousand USD | -46.1% |
| 2014 | 534.5 Thousand USD | -14.26% |
| 2013 | 623.36 Thousand USD | 8.99% |
| 2012 | 571.97 Thousand USD | 413.06% |
| 2011 | 111.48 Thousand USD | -22.56% |
| 2010 | 143.95 Thousand USD | 1895.39% |
| 2009 | -8018.00 USD | -118.44% |
| 2008 | 43.48 Thousand USD | -45.63% |
| 2007 | 79.96 Thousand USD | 430.87% |
| 2006 | -24.16 Thousand USD | 0.0% |
| 2005 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 752.3 Thousand USD | 7.9% |
| 2024 Q1 | 697.2 Thousand USD | 1.13% |
| 2023 Q3 | 710.13 Thousand USD | 7.25% |
| 2023 FY | 689.4 Thousand USD | 2.25% |
| 2023 Q2 | 662.13 Thousand USD | -0.48% |
| 2023 Q1 | 665.32 Thousand USD | -1.33% |
| 2023 Q4 | 689.4 Thousand USD | -2.92% |
| 2022 Q4 | 674.26 Thousand USD | -5.05% |
| 2022 Q2 | 659.59 Thousand USD | 44.61% |
| 2022 Q1 | 456.12 Thousand USD | 131.3% |
| 2022 FY | 674.26 Thousand USD | 241.92% |
| 2022 Q3 | 710.14 Thousand USD | 7.66% |
| 2021 Q4 | 197.2 Thousand USD | 231.95% |
| 2021 FY | 197.2 Thousand USD | -61.62% |
| 2021 Q1 | -144.77 Thousand USD | -128.17% |
| 2021 Q3 | -149.44 Thousand USD | -752.42% |
| 2021 Q2 | -17.53 Thousand USD | 87.89% |
| 2020 Q1 | 25.94 Thousand USD | -92.57% |
| 2020 Q3 | 556.29 Thousand USD | 330.43% |
| 2020 Q4 | 513.87 Thousand USD | -7.62% |
| 2020 FY | 513.87 Thousand USD | 47.17% |
| 2020 Q2 | 129.24 Thousand USD | 398.06% |
| 2019 Q4 | 349.16 Thousand USD | 495.79% |
| 2019 Q3 | -88.21 Thousand USD | 82.39% |
| 2019 FY | 349.16 Thousand USD | 1608.12% |
| 2019 Q2 | -500.89 Thousand USD | -507.86% |
| 2019 Q1 | 122.81 Thousand USD | 630.46% |
| 2018 Q1 | 38.66 Thousand USD | -85.18% |
| 2018 Q4 | -23.15 Thousand USD | -159.46% |
| 2018 Q2 | -139.42 Thousand USD | -460.63% |
| 2018 Q3 | 38.94 Thousand USD | 127.93% |
| 2018 FY | -23.15 Thousand USD | -108.87% |
| 2017 Q4 | 260.88 Thousand USD | -35.46% |
| 2017 Q2 | 444.34 Thousand USD | 13.32% |
| 2017 FY | 260.88 Thousand USD | -12.74% |
| 2017 Q1 | 392.11 Thousand USD | 31.16% |
| 2017 Q3 | 404.25 Thousand USD | -9.02% |
| 2016 FY | 298.96 Thousand USD | 3.78% |
| 2016 Q3 | 148.45 Thousand USD | 14.89% |
| 2016 Q4 | 298.96 Thousand USD | 101.39% |
| 2016 Q1 | 102.25 Thousand USD | -64.51% |
| 2016 Q2 | 129.2 Thousand USD | 26.36% |
| 2015 Q3 | 13.41 Thousand USD | -64.71% |
| 2015 Q1 | -47.88 Thousand USD | -108.96% |
| 2015 Q2 | 37.99 Thousand USD | 179.34% |
| 2015 Q4 | 288.07 Thousand USD | 2048.24% |
| 2015 FY | 288.07 Thousand USD | -46.1% |
| 2014 Q2 | 827.43 Thousand USD | 20.38% |
| 2014 Q4 | 534.5 Thousand USD | -42.03% |
| 2014 FY | 534.5 Thousand USD | -14.26% |
| 2014 Q1 | 687.35 Thousand USD | 10.27% |
| 2014 Q3 | 922.02 Thousand USD | 11.43% |
| 2013 Q4 | 623.36 Thousand USD | 27.59% |
| 2013 Q2 | 474.86 Thousand USD | -19.4% |
| 2013 Q3 | 488.56 Thousand USD | 2.88% |
| 2013 Q1 | 589.18 Thousand USD | 3.01% |
| 2013 FY | 623.36 Thousand USD | 8.99% |
| 2012 Q3 | 120.77 Thousand USD | 2.59% |
| 2012 FY | 571.97 Thousand USD | 413.06% |
| 2012 Q4 | 571.97 Thousand USD | 373.6% |
| 2012 Q2 | 117.71 Thousand USD | 2.71% |
| 2012 Q1 | 114.61 Thousand USD | 2.81% |
| 2011 FY | 111.48 Thousand USD | -22.56% |
| 2011 Q1 | 431.83 Thousand USD | 199.98% |
| 2011 Q3 | 400.79 Thousand USD | 199.55% |
| 2011 Q2 | 133.8 Thousand USD | -69.02% |
| 2011 Q4 | 111.48 Thousand USD | -72.18% |
| 2010 Q2 | 597.95 Thousand USD | 215.69% |
| 2010 Q3 | 69.16 Thousand USD | -88.43% |
| 2010 Q4 | 143.95 Thousand USD | 108.14% |
| 2010 FY | 143.95 Thousand USD | 1895.39% |
| 2010 Q1 | 189.41 Thousand USD | 2462.32% |
| 2009 FY | -8018.00 USD | -118.44% |
| 2009 Q1 | 48.14 Thousand USD | 10.72% |
| 2009 Q2 | 26.57 Thousand USD | -44.8% |
| 2009 Q3 | 56.93 Thousand USD | 114.24% |
| 2009 Q4 | -8018.00 USD | -114.08% |
| 2008 Q4 | 43.48 Thousand USD | 140.34% |
| 2008 Q3 | -107.8 Thousand USD | -202.74% |
| 2008 Q2 | 104.92 Thousand USD | 8.33% |
| 2008 Q1 | 96.85 Thousand USD | 21.12% |
| 2008 FY | 43.48 Thousand USD | -45.63% |
| 2007 Q1 | 31.69 Thousand USD | 231.15% |
| 2007 FY | 79.96 Thousand USD | 430.87% |
| 2007 Q4 | 79.96 Thousand USD | 0.11% |
| 2007 Q3 | 79.88 Thousand USD | 24.63% |
| 2007 Q2 | 64.09 Thousand USD | 102.22% |
| 2006 Q4 | -24.16 Thousand USD | 39.72% |
| 2006 Q3 | -40.09 Thousand USD | 0.0% |
| 2006 FY | -24.16 Thousand USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -37.724% |
| Ansell Limited | -54.99 Million USD | 101.201% |
| Ansell Limited | -55.1 Million USD | 101.199% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 101.81% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 728.503% |
| Psykey, Inc. | 634.59 Thousand USD | -4.093% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.945% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.945% |
| Encision Inc. | 1.29 Million USD | 48.821% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 71.388% |
| Innovative MedTech Inc. | 1.76 Million USD | 62.568% |
| LifePoint, Inc. | -3.26 Million USD | 120.238% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 86.53% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 69.446% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 1625.423% |
| Reflect Scientific, Inc. | -1.03 Million USD | 163.804% |
| SmileDirectClub, Inc. | 778.67 Million USD | 99.915% |
| Sector 10, Inc. | 163 Thousand USD | -305.257% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 100.158% |
| SheerVision, Inc. | 57.34 Thousand USD | -1051.84% |
| Vasamed, Inc. | 22.12 Thousand USD | -2886.027% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 74.895% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 14.465% |